FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Leukoc Biol / Modeling asthma: Pitfalls, promises, and the road ahead.
Journal of leukocyte biology2018; 104(1); 41-48; doi: 10.1002/JLB.3MR1117-436R

Modeling asthma: Pitfalls, promises, and the road ahead.

Abstract: Asthma is a chronic, heterogeneous, and recurring inflammatory disease of the lower airways, with exacerbations that feature airway inflammation and bronchial hyperresponsiveness. Asthma has been modeled extensively via disease induction in both wild-type and genetically manipulated laboratory mice (Mus musculus). Antigen sensitization and challenge strategies have reproduced numerous important features of airway inflammation characteristic of human asthma, notably the critical roles of type 2 T helper cell cytokines. Recent models of disease induction have advanced to include physiologic aeroallergens with prolonged respiratory challenge without systemic sensitization; others incorporate tobacco, respiratory viruses, or bacteria as exacerbants. Nonetheless, differences in lung size, structure, and physiologic responses limit the degree to which airway dynamics measured in mice can be compared to human subjects. Other rodent allergic airways models, including those featuring the guinea pig (Cavia porcellus) might be considered for lung function studies. Finally, domestic cats (Feline catus) and horses (Equus caballus) develop spontaneous obstructive airway disorders with clinical and pathologic features that parallel human asthma. Information on pathogenesis and treatment of these disorders is an important resource.
©2018 Society for Leukocyte Biology.
Get Full Text
Publication Date: 2018-02-16 PubMed ID: 29451705PubMed Central: PMC6134392DOI: 10.1002/JLB.3MR1117-436RGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Intramural
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the effectiveness and limitations of using different animal models for studying asthma, a recurring inflammatory disease, which affects the lower airways. The article emphasizes the importance of examining diverse experimental models, including mice, guinea pigs, cats, and horses, to research disease induction, airway inflammation, and potential treatments.

Experimental Models for Asthma Research

  • Asthma has been extensively modeled in both wild-type and genetically manipulated mice (Mus musculus). Certain antigen sensitization and disease induction strategies have been successful in reproducing critical features of airway inflammation characteristic of human asthma – notably highlighting the role of type 2 T helper cell cytokines.
  • Most recent disease induction strategies have evolved to include natural aeroallergens with prolonged respiratory challenges without systemic sensitization. Some also integrate tobacco, respiratory viruses, or bacteria as factors to induce exacerbation.

Limitations of Using Mouse Models

  • There are limitations to using mice as models for asthma research. Differences exist in lung size, structure, and physiological responses between mice and humans, which limit to what extent airway dynamics measured in mice would directly parallel human subjects.
  • These differences may make it challenging to apply the outcomes directly to human conditions and may result in failed clinical trials due to the over-reliance on mouse models as predictors of human responses.

Alternative Animal Models

  • The researchers also suggested that other rodent allergic models featuring the guinea pig (Cavia porcellus) might be considered for lung function studies due to their closer resemblance to human respiratory systems.
  • They also highlight the potential of domestic cats (Feline catus) and horses (Equus caballus) as models. Cats and horses develop spontaneous obstructive airway disorders with clinical and pathological features parallel to human asthma. Thus, information gathered from studying these disorders in these animals could be a valuable resource for understanding pathogenesis and treatment of asthma in humans.

The research underscores the need for broader and diversified experimental animal models to better understand asthma pathology and devise efficacious treatments for the heterogeneous disease. It emphasizes the importance of not over-relying on a single model, but rather adopting a comprehensive multi-model approach to advance asthma research.

Cite This Article

APA
Rosenberg HF, Druey KM. (2018). Modeling asthma: Pitfalls, promises, and the road ahead. J Leukoc Biol, 104(1), 41-48. https://doi.org/10.1002/JLB.3MR1117-436R

Publication

Journal of leukocyte biology
ISSN: 1938-3673
NlmUniqueID: 8405628
Country: England
Language: English
Volume: 104
Issue: 1
Pages: 41-48

Researcher Affiliations

Rosenberg, Helene F
  • Inflammation Immunobiology Section and Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Druey, Kirk M
  • Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

MeSH Terms

  • Animals
  • Asthma
  • Disease Models, Animal
  • Humans

Grant Funding

  • Z01 AI000939 / Intramural NIH HHS
  • Z01 AI000939-05 / Intramural NIH HHS
  • Z01 AI000941 / Intramural NIH HHS
  • ZIA AI000941-13 / Intramural NIH HHS

References

This article includes 99 references
  1. Expert Panel Report-3 from the National Heart, Lung and Blood Association, Bethesda, MD: nhttps://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf
  2. Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children.. J Allergy Clin Immunol 2017 Oct;140(4):895-906.
    pmc: PMC7172811pubmed: 28987219doi: 10.1016/j.jaci.2017.08.003google scholar: lookup
  3. Castillo JR, Peters SP, Busse WW. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.. J Allergy Clin Immunol Pract 2017 Jul-Aug;5(4):918-927.
    pmc: PMC5950727pubmed: 28689842doi: 10.1016/j.jaip.2017.05.001google scholar: lookup
  4. Schiavoni G, D'Amato G, Afferni C. The dangerous liaison between pollens and pollution in respiratory allergy.. Ann Allergy Asthma Immunol 2017 Mar;118(3):269-275.
    pubmed: 28143681doi: 10.1016/j.anai.2016.12.019google scholar: lookup
  5. Zhang Z, Reponen T, Hershey GK. Fungal Exposure and Asthma: IgE and Non-IgE-Mediated Mechanisms.. Curr Allergy Asthma Rep 2016 Nov;16(12):86.
    pmc: PMC6156787pubmed: 27943046doi: 10.1007/s11882-016-0667-9google scholar: lookup
  6. Brightling CE. Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators.. Allergy Asthma Proc 2016 Nov;37(6):432-438.
    pubmed: 27931297doi: 10.2500/aap.2016.37.3996google scholar: lookup
  7. Kumar RK, Herbert C, Foster PS. Mouse models of acute exacerbations of allergic asthma.. Respirology 2016 Jul;21(5):842-9.
    pubmed: 26922049doi: 10.1111/resp.12760google scholar: lookup
  8. Lloyd CM. Building better mouse models of asthma.. Curr Allergy Asthma Rep 2007 Jun;7(3):231-6.
    pmc: PMC3384569pubmed: 17448336doi: 10.1007/s11882-007-0077-0google scholar: lookup
  9. Shin YS, Takeda K, Gelfand EW. Understanding asthma using animal models.. Allergy Asthma Immunol Res 2009 Oct;1(1):10-8.
    pmc: PMC2831565pubmed: 20224665doi: 10.4168/aair.2009.1.1.10google scholar: lookup
  10. Jacobsen EA, Lee NA, Lee JJ. Re-defining the unique roles for eosinophils in allergic respiratory inflammation.. Clin Exp Allergy 2014 Sep;44(9):1119-36.
    pmc: PMC4148640pubmed: 24961290doi: 10.1111/cea.12358google scholar: lookup
  11. Epstein MM, Tilp C, Erb KJ. The Use of Mouse Asthma Models to Successfully Discover and Develop Novel Drugs.. Int Arch Allergy Immunol 2017;173(2):61-70.
    pubmed: 28586774doi: 10.1159/000473699google scholar: lookup
  12. Chapman DG, Tully JE, Nolin JD, Janssen-Heininger YM, Irvin CG. Animal models of allergic airways disease: where are we and where to next?. J Cell Biochem 2014 Dec;115(12):2055-64.
    pmc: PMC4199895pubmed: 25043224doi: 10.1002/jcb.24881google scholar: lookup
  13. Persson CG. Con: mice are not a good model of human airway disease.. Am J Respir Crit Care Med 2002 Jul 1;166(1):6-7; discussion 8.
    pubmed: 12091161doi: 10.1164/rccm.2204001google scholar: lookup
  14. Williams K, Roman J. Studying human respiratory disease in animals--role of induced and naturally occurring models.. J Pathol 2016 Jan;238(2):220-32.
    pubmed: 26467890doi: 10.1002/path.4658google scholar: lookup
  15. Gershwin LJ. Comparative immunology of allergic responses.. Annu Rev Anim Biosci 2015;3:327-46.
    pubmed: 25422854doi: 10.1146/annurev-animal-022114-110930google scholar: lookup
  16. Sakula A. Henry Hyde Salter (1823-71): a biographical sketch.. Thorax 1985 Dec;40(12):887-8.
    pmc: PMC460219pubmed: 3913047doi: 10.1136/thx.40.12.887google scholar: lookup
  17. Spina D, Page CP. Xanthines and Phosphodiesterase Inhibitors.. Handb Exp Pharmacol 2017;237:63-91.
    pubmed: 27844172doi: 10.1007/164_2016_71google scholar: lookup
  18. Holgate ST. A brief history of asthma and its mechanisms to modern concepts of disease pathogenesis.. Allergy Asthma Immunol Res 2010 Jul;2(3):165-71.
    pmc: PMC2892047pubmed: 20592914doi: 10.4168/aair.2010.2.3.165google scholar: lookup
  19. HARRIS MS. Cortisone in treatment of bronchial asthma.. Calif Med 1951 Aug;75(2):85-8.
    pmc: PMC1520983pubmed: 14848726
  20. Vernon DR, Macleod JM, Kerr JW. A 12-month double-blind assessment of betamethasone valerate aerosol in the management of asthma.. Clin Allergy 1976 May;6(3):261-6.
    pubmed: 780001doi: 10.1111/j.1365-2222.1976.tb01905.xgoogle scholar: lookup
  21. Ishizaka K, Ishizaka T. Identification of IgE.. J Allergy Clin Immunol 2016 Jun;137(6):1646-1650.
    pubmed: 27090936doi: 10.1016/j.jaci.2015.12.1343google scholar: lookup
  22. Saito H, Ishizaka T, Ishizaka K. Mast cells and IgE: from history to today.. Allergol Int 2013 Mar;62(1):3-12.
    pubmed: 23439053doi: 10.2332/allergolint.13-rai-0537google scholar: lookup
  23. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.. Annu Rev Immunol 1989;7:145-73.
    pubmed: 2523712doi: 10.1146/annurev.iy.07.040189.001045google scholar: lookup
  24. Ebbo M, Crinier A, Vély F, Vivier E. Innate lymphoid cells: major players in inflammatory diseases.. Nat Rev Immunol 2017 Nov;17(11):665-678.
    pubmed: 28804130doi: 10.1038/nri.2017.86google scholar: lookup
  25. Fajt ML, Wenzel SE. Development of New Therapies for Severe Asthma.. Allergy Asthma Immunol Res 2017 Jan;9(1):3-14.
    pmc: PMC5102833pubmed: 27826957doi: 10.4168/aair.2017.9.1.3google scholar: lookup
  26. Ray A, Raundhal M, Oriss TB, Ray P, Wenzel SE. Current concepts of severe asthma.. J Clin Invest 2016 Jul 1;126(7):2394-403.
    pmc: PMC4922699pubmed: 27367183doi: 10.1172/jci84144google scholar: lookup
  27. Chung KF. Precision medicine in asthma: linking phenotypes to targeted treatments.. Curr Opin Pulm Med 2018 Jan;24(1):4-10.
    pubmed: 29036018doi: 10.1097/mcp.0000000000000434google scholar: lookup
  28. Russell RJ, Brightling C. Pathogenesis of asthma: implications for precision medicine.. Clin Sci (Lond) 2017 Jul 15;131(14):1723-1735.
    pubmed: 28667070doi: 10.1042/cs20160253google scholar: lookup
  29. Svenningsen S, Nair P. Asthma Endotypes and an Overview of Targeted Therapy for Asthma.. Front Med (Lausanne) 2017;4:158.
    pmc: PMC5622943pubmed: 29018800doi: 10.3389/fmed.2017.00158google scholar: lookup
  30. Brusselle GG, Vanderstichele C, Jordens P, Deman R, Slabbynck H, Ringoet V, Verleden G, Demedts IK, Verhamme K, Delporte A, Demeyere B, Claeys G, Boelens J, Padalko E, Verschakelen J, Van Maele G, Deschepper E, Joos GF. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.. Thorax 2013 Apr;68(4):322-9.
    pubmed: 23291349doi: 10.1136/thoraxjnl-2012-202698google scholar: lookup
  31. Chupp G, Laviolette M, Cohn L, McEvoy C, Bansal S, Shifren A, Khatri S, Grubb GM, McMullen E, Strauven R, Kline JN. Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.. Eur Respir J 2017 Aug;50(2).
    pmc: PMC5593347pubmed: 28860266doi: 10.1183/13993003.00017-2017google scholar: lookup
  32. Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma.. Ann Allergy Asthma Immunol 2011 Jul;107(1):65-70.
    pubmed: 21704887doi: 10.1016/j.anai.2011.03.005google scholar: lookup
  33. Humbert M, Busse W, Hanania NA. Controversies and opportunities in severe asthma.. Curr Opin Pulm Med 2018 Jan;24(1):83-93.
    pubmed: 29059087doi: 10.1097/mcp.0000000000000438google scholar: lookup
  34. Poulakos MN, Cargill SM, Waineo MF, Wolford AL Jr. Mepolizumab for the treatment of severe eosinophilic asthma.. Am J Health Syst Pharm 2017 Jul 1;74(13):963-969.
    pubmed: 28645995doi: 10.2146/ajhp160291google scholar: lookup
  35. Chupp GL, Bradford ES, Albers FC, Bratton DJ, Wang-Jairaj J, Nelsen LM, Trevor JL, Magnan A, Ten Brinke A. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.. Lancet Respir Med 2017 May;5(5):390-400.
    pubmed: 28395936doi: 10.1016/s2213-2600(17)30125-xgoogle scholar: lookup
  36. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, Hamilton J, Ming JE, Radin A, Stahl N, Yancopoulos GD, Graham N, Pirozzi G. Dupilumab in persistent asthma with elevated eosinophil levels.. N Engl J Med 2013 Jun 27;368(26):2455-66.
    pubmed: 23688323doi: 10.1056/nejmoa1304048google scholar: lookup
  37. Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, Pirozzi G, Sutherland ER, Evans RR, Joish VN, Eckert L, Graham NM, Stahl N, Yancopoulos GD, Louis-Tisserand M, Teper A. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.. Lancet 2016 Jul 2;388(10039):31-44.
    pubmed: 27130691doi: 10.1016/s0140-6736(16)30307-5google scholar: lookup
  38. Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R. Tezepelumab in Adults with Uncontrolled Asthma.. N Engl J Med 2017 Sep 7;377(10):936-946.
    pubmed: 28877011doi: 10.1056/nejmoa1704064google scholar: lookup
  39. Hau J. Chapter 1. Animal models for human diseases. An overview. Sourcebook of models for biomedical research 2008; pp. 3–8.
  40. Kumar RK, Herbert C, Foster PS. The "classical" ovalbumin challenge model of asthma in mice.. Curr Drug Targets 2008 Jun;9(6):485-94.
    pubmed: 18537587doi: 10.2174/138945008784533561google scholar: lookup
  41. Gao P. Sensitization to cockroach allergen: immune regulation and genetic determinants.. Clin Dev Immunol 2012;2012:563760.
    pmc: PMC3261483pubmed: 22272212doi: 10.1155/2012/563760google scholar: lookup
  42. Ochkur SI, Jacobsen EA, Protheroe CA, Biechele TL, Pero RS, McGarry MP, Wang H, O'Neill KR, Colbert DC, Colby TV, Shen H, Blackburn MR, Irvin CC, Lee JJ, Lee NA. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma.. J Immunol 2007 Jun 15;178(12):7879-89.
    pubmed: 17548626doi: 10.4049/jimmunol.178.12.7879google scholar: lookup
  43. Gour N, Wills-Karp M. IL-4 and IL-13 signaling in allergic airway disease.. Cytokine 2015 Sep;75(1):68-78.
    pmc: PMC4532591pubmed: 26070934doi: 10.1016/j.cyto.2015.05.014google scholar: lookup
  44. Foster PS, Maltby S, Rosenberg HF, Tay HL, Hogan SP, Collison AM, Yang M, Kaiko GE, Hansbro PM, Kumar RK, Mattes J. Modeling T(H) 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma.. Immunol Rev 2017 Jul;278(1):20-40.
    pmc: PMC5492958pubmed: 28658543doi: 10.1111/imr.12549google scholar: lookup
  45. Trzil JE, Reinero CR. Update on feline asthma.. Vet Clin North Am Small Anim Pract 2014 Jan;44(1):91-105.
    pubmed: 24268335doi: 10.1016/j.cvsm.2013.08.006google scholar: lookup
  46. Bullone M, Lavoie JP. Asthma "of horses and men"--how can equine heaves help us better understand human asthma immunopathology and its functional consequences?. Mol Immunol 2015 Jul;66(1):97-105.
    pubmed: 25547716doi: 10.1016/j.molimm.2014.12.005google scholar: lookup
  47. Jensen-Jarolim E, Einhorn L, Herrmann I, Thalhammer JG, Panakova L. Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities.. Clin Transl Allergy 2015;5:15.
    pmc: PMC4387677pubmed: 25852853doi: 10.1186/s13601-015-0059-6google scholar: lookup
  48. Darowski MJ, Hannon VM, Hirshman CA. Corticosteroids decrease airway hyperresponsiveness in the Basenji-Greyhound dog model of asthma.. J Appl Physiol (1985) 1989 Mar;66(3):1120-6.
    pubmed: 2708237doi: 10.1152/jappl.1989.66.3.1120google scholar: lookup
  49. Hug LA, Baker BJ, Anantharaman K, Brown CT, Probst AJ, Castelle CJ, Butterfield CN, Hernsdorf AW, Amano Y, Ise K, Suzuki Y, Dudek N, Relman DA, Finstad KM, Amundson R, Thomas BC, Banfield JF. A new view of the tree of life.. Nat Microbiol 2016 Apr 11;1:16048.
    pubmed: 27572647doi: 10.1038/nmicrobiol.2016.48google scholar: lookup
  50. Graur D, Li W-H. Fundamentals of Molecular Evolution. 1991; p. 139.
  51. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, Gregory S, Guigó R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, Kent WJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S, Ma B, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, McCarthy M, McCombie WR, McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta-Vidal A, Vinson JP, Von Niederhausern AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES. Initial sequencing and comparative analysis of the mouse genome.. Nature 2002 Dec 5;420(6915):520-62.
    pubmed: 12466850doi: 10.1038/nature01262google scholar: lookup
  52. Kapetanovic R, Arrifin JK, Sweet MJ. Evolutionary divergence in human versus mouse innate immune genes. Evolutionary biology: genome evolution, speciation, coevolution and origin of life 2014; pp. 115 – 155.
  53. Silver LM. Mouse genetics: concepts and applications. 2008.
  54. Bagg HJ. Individual differences and family resemblances in animal behavior. Amer. Nat 1916; 50: 222–236.
  55. Potter M. History of the BALB/c family.. Curr Top Microbiol Immunol 1985;122:1-5.
    pubmed: 3899522doi: 10.1007/978-3-642-70740-7_1google scholar: lookup
  56. Jackson RB, Little CC. THE EXISTENCE OF NON-CHROMOSOMAL INFLUENCE IN THE INCIDENCE OF MAMMARY TUMORS IN MICE.. Science 1933 Nov 17;78(2029):465-6.
    pubmed: 17752094doi: 10.1126/science.78.2029.465google scholar: lookup
  57. Simon MM, Greenaway S, White JK, Fuchs H, Gailus-Durner V, Wells S, Sorg T, Wong K, Bedu E, Cartwright EJ, Dacquin R, Djebali S, Estabel J, Graw J, Ingham NJ, Jackson IJ, Lengeling A, Mandillo S, Marvel J, Meziane H, Preitner F, Puk O, Roux M, Adams DJ, Atkins S, Ayadi A, Becker L, Blake A, Brooker D, Cater H, Champy MF, Combe R, Danecek P, di Fenza A, Gates H, Gerdin AK, Golini E, Hancock JM, Hans W, Hölter SM, Hough T, Jurdic P, Keane TM, Morgan H, Müller W, Neff F, Nicholson G, Pasche B, Roberson LA, Rozman J, Sanderson M, Santos L, Selloum M, Shannon C, Southwell A, Tocchini-Valentini GP, Vancollie VE, Westerberg H, Wurst W, Zi M, Yalcin B, Ramirez-Solis R, Steel KP, Mallon AM, de Angelis MH, Herault Y, Brown SD. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains.. Genome Biol 2013 Jul 31;14(7):R82.
    pmc: PMC4053787pubmed: 23902802doi: 10.1186/gb-2013-14-7-r82google scholar: lookup
  58. Boot R, Walvoort HC. Otitis media in guinea pigs: pathology and bacteriology.. Lab Anim 1986 Jul;20(3):242-8.
    pubmed: 3795863doi: 10.1258/002367786780865601google scholar: lookup
  59. Keyhani M, Naghshineh R. Spontaneous epizootic of pneumococcus infection in guinea-pigs.. Lab Anim 1974 Jan;8(1):47-9.
    pubmed: 4149340doi: 10.1258/002367774780943977google scholar: lookup
  60. Wright JL, Postma DS, Kerstjens HA, Timens W, Whittaker P, Churg A. Airway remodeling in the smoke exposed guinea pig model.. Inhal Toxicol 2007 Sep;19(11):915-23.
    pubmed: 17849276doi: 10.1080/08958370701515563google scholar: lookup
  61. Canning BJ, Chou Y. Using guinea pigs in studies relevant to asthma and COPD.. Pulm Pharmacol Ther 2008 Oct;21(5):702-20.
    pmc: PMC2882537pubmed: 18462968doi: 10.1016/j.pupt.2008.01.004google scholar: lookup
  62. Gleich GJ. The eosinophil: new aspects of structure and function.. J Allergy Clin Immunol 1977 Jul;60(1):73-82.
    pubmed: 326849doi: 10.1016/0091-6749(77)90086-0google scholar: lookup
  63. Takatsu K. Interleukin-5 and IL-5 receptor in health and diseases.. Proc Jpn Acad Ser B Phys Biol Sci 2011;87(8):463-85.
    pmc: PMC3313690pubmed: 21986312doi: 10.2183/pjab.87.463google scholar: lookup
  64. Takatsu K, Nakajima H. IL-5 and eosinophilia.. Curr Opin Immunol 2008 Jun;20(3):288-94.
    pubmed: 18511250doi: 10.1016/j.coi.2008.04.001google scholar: lookup
  65. Parulekar AD, Kao CC, Diamant Z, Hanania NA. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.. Curr Opin Pulm Med 2018 Jan;24(1):50-55.
    pubmed: 29036019doi: 10.1097/mcp.0000000000000436google scholar: lookup
  66. Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.. Int Arch Allergy Immunol 2016;170(2):122-31.
    pubmed: 27637004doi: 10.1159/000447692google scholar: lookup
  67. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies.. Nat Rev Immunol 2015 May;15(5):271-82.
    pubmed: 25882242doi: 10.1038/nri3831google scholar: lookup
  68. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA. Defining a link with asthma in mice congenitally deficient in eosinophils.. Science 2004 Sep 17;305(5691):1773-6.
    pubmed: 15375267doi: 10.1126/science.1099472google scholar: lookup
  69. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, Gerard C. A critical role for eosinophils in allergic airways remodeling.. Science 2004 Sep 17;305(5691):1776-9.
    pubmed: 15375268doi: 10.1126/science.1100283google scholar: lookup
  70. Lee JJ, Jacobsen EA, Ochkur SI, McGarry MP, Condjella RM, Doyle AD, Luo H, Zellner KR, Protheroe CA, Willetts L, Lesuer WE, Colbert DC, Helmers RA, Lacy P, Moqbel R, Lee NA. Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".. J Allergy Clin Immunol 2012 Sep;130(3):572-84.
    pmc: PMC3496419pubmed: 22935586doi: 10.1016/j.jaci.2012.07.025google scholar: lookup
  71. Clark K, Simson L, Newcombe N, Koskinen AM, Mattes J, Lee NA, Lee JJ, Dent LA, Matthaei KI, Foster PS. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen.. J Leukoc Biol 2004 Jun;75(6):1001-9.
    pubmed: 15020648doi: 10.1189/jlb.0803391google scholar: lookup
  72. Lee JJ, Lee NA. Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function?. Clin Exp Allergy 2005 Aug;35(8):986-94.
    pubmed: 16120079doi: 10.1111/j.1365-2222.2005.02302.xgoogle scholar: lookup
  73. O'Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma.. J Allergy Clin Immunol 2001 Oct;108(4):503-8.
    pubmed: 11590372doi: 10.1067/mai.2001.119149google scholar: lookup
  74. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.. N Engl J Med 2009 Mar 5;360(10):985-93.
    pubmed: 19264687doi: 10.1056/nejmoa0805435google scholar: lookup
  75. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma.. N Engl J Med 2009 Mar 5;360(10):973-84.
    pmc: PMC3992367pubmed: 19264686doi: 10.1056/nejmoa0808991google scholar: lookup
  76. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.. J Immunol 2012 Feb 1;188(3):1503-13.
    pmc: PMC3262877pubmed: 22198948doi: 10.4049/jimmunol.1102832google scholar: lookup
  77. Valladao AC, Frevert CW, Koch LK, Campbell DJ, Ziegler SF. STAT6 Regulates the Development of Eosinophilic versus Neutrophilic Asthma in Response to Alternaria alternata.. J Immunol 2016 Dec 15;197(12):4541-4551.
    pmc: PMC5136320pubmed: 27815425doi: 10.4049/jimmunol.1600007google scholar: lookup
  78. Geslewitz WE, Percopo CM, Rosenberg HF. Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.. Clin Exp Allergy 2018 Jan;48(1):29-38.
    pmc: PMC5746458pubmed: 29068539doi: 10.1111/cea.13050google scholar: lookup
  79. Starkey MR, Jarnicki AG, Essilfie AT, Gellatly SL, Kim RY, Brown AC, Foster PS, Horvat JC, Hansbro PM. Murine models of infectious exacerbations of airway inflammation.. Curr Opin Pharmacol 2013 Jun;13(3):337-44.
    pubmed: 23566696doi: 10.1016/j.coph.2013.03.005google scholar: lookup
  80. Siegle JS, Hansbro N, Herbert C, Rosenberg HF, Domachowske JB, Asquith KL, Foster PS, Kumar RK. Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice.. Respir Res 2010 Feb 3;11(1):14.
    pmc: PMC2842242pubmed: 20122285doi: 10.1186/1465-9921-11-14google scholar: lookup
  81. Maes T, Provoost S, Lanckacker EA, Cataldo DD, Vanoirbeek JA, Nemery B, Tournoy KG, Joos GF. Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation.. Respir Res 2010 Jan 21;11(1):7.
    pmc: PMC2831838pubmed: 20092634doi: 10.1186/1465-9921-11-7google scholar: lookup
  82. Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size.. Respir Res 2003;4(1):4.
    pmc: PMC184039pubmed: 12783622doi: 10.1186/rr199google scholar: lookup
  83. Drazen JM, Finn PW, De Sanctis GT. Mouse models of airway responsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators.. Annu Rev Physiol 1999;61:593-625.
    pubmed: 10099703doi: 10.1146/annurev.physiol.61.1.593google scholar: lookup
  84. Verheijden KA, Henricks PA, Redegeld FA, Garssen J, Folkerts G. Measurement of airway function using invasive and non-invasive methods in mild and severe models for allergic airway inflammation in mice.. Front Pharmacol 2014;5:190.
    pmc: PMC4129625pubmed: 25161620doi: 10.3389/fphar.2014.00190google scholar: lookup
  85. Tomioka S, Bates JH, Irvin CG. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations.. J Appl Physiol (1985) 2002 Jul;93(1):263-70.
    pubmed: 12070213doi: 10.1152/japplphysiol.01129.2001google scholar: lookup
  86. Shibly S, Klang A, Galler A, Schwendenwein I, Christian M, Guija A, Tichy A, Hirt RA. Architecture and inflammatory cell composition of the feline lung with special consideration of eosinophil counts.. J Comp Pathol 2014 May;150(4):408-15.
    pubmed: 24529513doi: 10.1016/j.jcpa.2013.12.007google scholar: lookup
  87. Reinero CR. Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma.. Vet J 2011 Oct;190(1):28-33.
    pubmed: 21036078doi: 10.1016/j.tvjl.2010.09.022google scholar: lookup
  88. Norris Reinero CR, Decile KC, Berghaus RD, Williams KJ, Leutenegger CM, Walby WF, Schelegle ES, Hyde DM, Gershwin LJ. An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen.. Int Arch Allergy Immunol 2004 Oct;135(2):117-31.
    pubmed: 15345910doi: 10.1159/000080654google scholar: lookup
  89. Cahill KN, Katz HR, Cui J, Lai J, Kazani S, Crosby-Thompson A, Garofalo D, Castro M, Jarjour N, DiMango E, Erzurum S, Trevor JL, Shenoy K, Chinchilli VM, Wechsler ME, Laidlaw TM, Boyce JA, Israel E. KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.. N Engl J Med 2017 May 18;376(20):1911-1920.
    pmc: PMC5568669pubmed: 28514613doi: 10.1056/nejmoa1613125google scholar: lookup
  90. Cordeau ME, Joubert P, Dewachi O, Hamid Q, Lavoie JP. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves.. Vet Immunol Immunopathol 2004 Jan;97(1-2):87-96.
    pubmed: 14700540doi: 10.1016/j.vetimm.2003.08.013google scholar: lookup
  91. Barton AK, Gehlen H. Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?. Mediators Inflamm 2016;2016:5693205.
    pmc: PMC5174180pubmed: 28053371doi: 10.1155/2016/5693205google scholar: lookup
  92. Bullone M, Vargas A, Elce Y, Martin JG, Lavoie JP. Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma.. Sci Rep 2017 Aug 18;7(1):8843.
    pmc: PMC5562887pubmed: 28821845doi: 10.1038/s41598-017-09414-8google scholar: lookup
  93. Léguillette R, Tohver T, Bond SL, Nicol JA, McDonald KJ. Effect of Dexamethasone and Fluticasone on Airway Hyperresponsiveness in Horses With Inflammatory Airway Disease.. J Vet Intern Med 2017 Jul;31(4):1193-1201.
    pmc: PMC5508307pubmed: 28568169doi: 10.1111/jvim.14740google scholar: lookup
  94. Debrue M, Hamilton E, Joubert P, Lajoie-Kadoch S, Lavoie JP. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells.. Vet Immunol Immunopathol 2005 May 1;105(1-2):25-31.
    pubmed: 15797472doi: 10.1016/j.vetimm.2004.12.013google scholar: lookup
  95. Beadle RE, Horohov DW, Gaunt SD. Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease affected horses.. Equine Vet J 2002 Jul;34(4):389-94.
    pubmed: 12117112doi: 10.2746/042516402776249119google scholar: lookup
  96. Giguère S, Viel L, Lee E, MacKay RJ, Hernandez J, Franchini M. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate.. Vet Immunol Immunopathol 2002 Mar;85(3-4):147-58.
    pubmed: 11943316doi: 10.1016/s0165-2427(01)00420-2google scholar: lookup
  97. Kolm G, Zappe H, Schmid R, Riedelberger K, Van den Hoven R. Efficacy of montelukast in the treatment of chronic obstructive pulmonary disease in five horses.. Vet Rec 2003 Jun 28;152(26):804-6.
    pubmed: 12862169doi: 10.1136/vr.152.26.804google scholar: lookup
  98. Lavoie JP, Pasloske K, Joubert P, Cordeau ME, Mancini J, Girard Y, Friesen RW, Frenette R, Blouin M, Young RN, Hickey G. Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses.. J Vet Intern Med 2006 Jan-Feb;20(1):175-81.
    pubmed: 16496938doi: 10.1892/0891-6640(2006)20[175:loceoa]2.0.co;2google scholar: lookup
  99. Bullone M, Beauchamp G, Godbout M, Martin JG, Lavoie JP. Endobronchial Ultrasound Reliably Quantifies Airway Smooth Muscle Remodeling in an Equine Asthma Model.. PLoS One 2015;10(9):e0136284.
    pmc: PMC4562526pubmed: 26348727doi: 10.1371/journal.pone.0136284google scholar: lookup

Citations

This article has been cited 12 times.
  1. Vientós-Plotts AI, Ericsson AC, McAdams ZL, Rindt H, Reinero CR. Temporal changes of the respiratory microbiota as cats transition from health to experimental acute and chronic allergic asthma.. Front Vet Sci 2022;9:983375.
    doi: 10.3389/fvets.2022.983375pubmed: 36090168google scholar: lookup
  2. Hazan G, Eubanks A, Gierasch C, Atkinson J, Fox C, Hernandez-Leyva A, Rosen AL, Kau AL, Agapov E, Alexander-Brett J, Steinberg D, Kelley D, White M, Byers D, Wu K, Keeler SP, Zhang Y, Koenitzer JR, Eiden E, Anderson N, Holtzman MJ, Haspel J. Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses.. J Immunol 2022 Mar 15;208(6):1467-1482.
    doi: 10.4049/jimmunol.2101094pubmed: 35173037google scholar: lookup
  3. Mainguy-Seers S, Boivin R, Pourali Dogaheh S, Beaudry F, Hélie P, Bonilla AG, Martin JG, Lavoie JP. Effects of azithromycin on bronchial remodeling in the natural model of severe neutrophilic asthma in horses.. Sci Rep 2022 Jan 10;12(1):446.
    doi: 10.1038/s41598-021-03955-9pubmed: 35013387google scholar: lookup
  4. Lourenço LO, Ribeiro AM, Lopes FDTQDS, Tibério IFLC, Tavares-de-Lima W, Prado CM. Different Phenotypes in Asthma: Clinical Findings and Experimental Animal Models.. Clin Rev Allergy Immunol 2022 Feb;62(1):240-263.
    doi: 10.1007/s12016-021-08894-xpubmed: 34542807google scholar: lookup
  5. Srinivasan A, Sundar IK. Recent updates on the role of extracellular vesicles in the pathogenesis of allergic asthma.. Extracell Vesicles Circ Nucl Acids 2021;2:127-147.
    doi: 10.20517/evcna.2021.03pubmed: 34414402google scholar: lookup
  6. Fettrelet T, Gigon L, Karaulov A, Yousefi S, Simon HU. The Enigma of Eosinophil Degranulation.. Int J Mol Sci 2021 Jun 30;22(13).
    doi: 10.3390/ijms22137091pubmed: 34209362google scholar: lookup
  7. Zhang J, Dong L. Status and prospects: personalized treatment and biomarker for airway remodeling in asthma.. J Thorac Dis 2020 Oct;12(10):6090-6101.
    doi: 10.21037/jtd-20-1024pubmed: 33209441google scholar: lookup
  8. Périz M, Pérez-Cano FJ, Rodríguez-Lagunas MJ, Cambras T, Pastor-Soplin S, Best I, Castell M, Massot-Cladera M. Development and Characterization of an Allergic Asthma Rat Model for Interventional Studies.. Int J Mol Sci 2020 May 28;21(11).
    doi: 10.3390/ijms21113841pubmed: 32481675google scholar: lookup
  9. Simon HU, Yousefi S, Germic N, Arnold IC, Haczku A, Karaulov AV, Simon D, Rosenberg HF. The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.. Int Arch Allergy Immunol 2020;181(1):11-23.
    doi: 10.1159/000504847pubmed: 31786573google scholar: lookup
  10. Dias IE, Pinto PO, Barros LC, Viegas CA, Dias IR, Carvalho PP. Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?. BMC Vet Res 2019 Oct 22;15(1):358.
    doi: 10.1186/s12917-019-2087-2pubmed: 31640767google scholar: lookup
  11. Paul AGA, Muehling LM, Eccles JD, Woodfolk JA. T cells in severe childhood asthma.. Clin Exp Allergy 2019 May;49(5):564-581.
    doi: 10.1111/cea.13374pubmed: 30793397google scholar: lookup
  12. Gahring LC, Myers EJ, Dunn DM, Weiss RB, Rogers SW. Lung eosinophilia induced by house dust mites or ovalbumin is modulated by nicotinic receptor α7 and inhibited by cigarette smoke.. Am J Physiol Lung Cell Mol Physiol 2018 Oct 1;315(4):L553-L562.
    doi: 10.1152/ajplung.00230.2018pubmed: 29975102google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.